Last reviewed · How we verify
NCT07347093
Reversal of Roux-en-Y Gastric Bypass: A Swedish National Cohort Study
trial in Gastric Bypass Surgery in 199 participants. Participants enrolled and being followed up; not accepting new ones.
31 March 2026
Quick facts
| Lead sponsor | Vrinnevi Hospital |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 199 |
| Start date | 1 November 2025 |
| Primary completion | 31 March 2026 |
| Estimated completion | 31 May 2026 |
| Sites | 1 location across Sweden |
Conditions studied
- Gastric Bypass Surgery — all drugs for Gastric Bypass Surgery →
- Revisional Bariatric Surgery — all drugs for Revisional Bariatric Surgery →
- Complications After Bariatric Surgery — all drugs for Complications After Bariatric Surgery →
Sponsor
Vrinnevi Hospital
Who can join
18 and older, any sex, with Gastric Bypass Surgery or Revisional Bariatric Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Objective: To investigates incidence, indications, symptom relief, complications, and weight outcomes after Roux-en-Y gastric bypass (RYGB) reversal. Background: RYGB is an effective treatment for obesity, but in rare cases may be associated with severe long-term complications requiring RYGB reversal. Evidence on incidence and outcomes is limited. Methods: This nationwide, multi-center, retrospective cohort study included all patients undergoing RYGB reversal in Sweden between 2007 and 2023. Data were obtained from the Scandinavian Obesity Surgery Registry (SOReg) and medical records.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07347093
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastric Bypass Surgery
Currently open trials in the same condition.
- NCT06468865 — Glucose Monitoring in Treatment of Postprandial Hypoglycemia After Gastric Bypass Surgery · NA · recruiting
Other Vrinnevi Hospital trials
Trials by the same sponsor.
- NCT06933303 — Distraction as Treatment for Pain in Children in Resource-scarce Settings · NA · recruiting
- NCT06348589 — Orthostatic Hypotension and Blood Pressure Variability in Persons Undergoing Hemodialysis · completed
- NCT06399666 — Impact of Inflammatory Indexes and Gene Scores in Prediction of Atrial Fibrillation · recruiting
- NCT03490305 — Penetrating Abdominal Injuries From the Battle of Mosul · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07347093 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vrinnevi Hospital
- Last refreshed: 20 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07347093.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing